Sir Robert Lechler has recently stepped down from his roles as Senior Vice-President (Health) at King’s College London and Executive Director of King’s Health Partners Academic Health Sciences Centre. He is currently Emeritus Senior Vice President (Health) at King’s College London, President of the Academy of Medical Sciences, Executive Director on the Board of Quell Therapeutics Limited and Senior Medical Adviser to Babylon Health.
He is a strong advocate of the Academic Health Science Centre model of university-healthcare partnerships. His clinical and research career have been focused on the pursuit of clinical transplantation tolerance. He worked in in vitro and in vivo rodent models and recently has helped to define biomarkers of clinical tolerance. This work has led to first in man trials of cell therapy to promote immune tolerance in recipients of kidney and liver organ transplants.
In 2012 Robert was awarded a Knighthood in the Queen’s Birthday honours for Services to Academic Medicine and in 2015 was elected as the President of the UK Academy of Medical Sciences. In addition, Robert was a Founding Board Member of MedCity, was a Board Member of the Crick Institute, sits on the HCA Healthcare Advisory Board and is a member of the Prime Minister’s Council for Science and Technology.